Cargando…
RIPK3 modulates sarcoma through immune checkpoint HAVCR2
Sarcomas is a complex group of malignant diseasse with undetermined molecular mechanisms. Receptor interacting serine/threonine kinase 3 (RIPK3) is a necroptosis- and apoptosis-related marker that has been implicated in several immune-associated diseases and aggressive malignant tumours. In the pres...
Autores principales: | Qian, Chen, Wu, Deluo, Du, Jianwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494677/ https://www.ncbi.nlm.nih.gov/pubmed/36238358 http://dx.doi.org/10.3892/ol.2022.13501 |
Ejemplares similares
-
A Regulatory Polymorphism in HAVCR2 Modulates Susceptibility to HIV-1 Infection
por: Sironi, Manuela, et al.
Publicado: (2014) -
Functional variants of TIM-3/HAVCR2 3′UTR in lymphoblastoid cell lines
por: Pu, Feifei, et al.
Publicado: (2018) -
Mathematical modeling identifies LAG3 and HAVCR2 as biomarkers of T cell exhaustion in melanoma
por: Beck, Richard J., et al.
Publicado: (2023) -
HAVCR1 expression might be a novel prognostic factor for gastric cancer
por: Liu, Lingling, et al.
Publicado: (2018) -
Treatment of an HLH-mimic disease based on HAVCR2 variants with absent TIM-3 expression
por: Tromp, Samantha A.M., et al.
Publicado: (2022)